PLIANT THERAPEUTICS, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2019 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Pliant Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2019 to Q3 2024.
  • Pliant Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 60.7M shares, a 1.75% increase year-over-year.
  • Pliant Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 58.7M shares, a 39.8% increase from 2022.
  • Pliant Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 42M shares, a 17.2% increase from 2021.
  • Pliant Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 35.8M shares, a 67.9% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 60.7M +1.04M +1.75% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 60.4M +1.21M +2.05% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 60.2M +4.12M +7.36% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 58.7M +16.7M +39.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 59.7M +12.9M +27.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 59.2M +23M +63.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 56.1M +19.9M +55.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 42M +6.17M +17.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 46.8M +10.9M +30.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 36.2M +426K +1.19% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 36.1M +471K +1.32% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 35.8M +14.5M +67.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 35.9M +461K +1.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 35.7M +23.5M +192% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 35.6M +33.7M +1778% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 21.3M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-01
Q3 2020 35.4M +33.7M +1968% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 12.3M +10.7M +686% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 1.9M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q3 2019 1.71M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 1.56M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.